Stock BGNE BEIGENE, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights BeiGene, Ltd.

Equities

BGNE

US07725L1026

Biotechnology & Medical Research

Real-time Estimate Cboe BZX
Other stock markets
 02:05:08 2024-12-11 pm EST 		5-day change 1st Jan Change
184.95 USD -1.36% Intraday chart for BeiGene, Ltd. -7.00% +2.66%
Dec. 10 Asian Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading MT
Dec. 10 BeiGene, Ltd. Advances Leadership in CLL at ASH 2024 with New Data from Its Hematology Franchise Including BRUKINSA and Novel Pipeline Assets CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
BeiGene Secures $400 Million Facility from China Merchants Bank
07:22am
 MT
BeiGene, Ltd. Advances Leadership in CLL at ASH 2024 with New Data from Its Hematology Franchise Including BRUKINSA and Novel Pipeline Assets
Dec. 09
 CI
BeiGene, Ltd. and CLL Society Partner to Advance Test Before Treat? Campaign, Promoting Biomarker Testing to Improve Patient Outcomes in CLL
Dec. 04
 CI
Astrazeneca's Enhertu, Orpathys Among 91 Drugs Added to China's National Reimbursement Drug List
Nov. 29
 MT
Hong Kong Stocks End Week in Green; Mokingran Jewellery Gains 8% in Debut
Nov. 29
 MT
BeiGene's Four Drugs Included in China's Medical Insurance Catalog; Shares Jump 5%
Nov. 29
 MT
Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Wednesday Ahead of Crucial Inflation Data
Nov. 27
 MT
European Commission Approves BeiGene?s TEVIMBRA for First-Line Treatment of Advanced/Metastatic Esophageal Squamous Cell Carcinoma and Gastric or Gastroesophageal Junction Cancer
Nov. 27
 CI
Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK
Nov. 21
 DJ
Sector Update: Health Care Stocks Advance Pre-Bell Thursday
Nov. 14
 MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of Powell Speech
Nov. 14
 MT
BeiGene Proposes Name Change
Nov. 14
 MT
BeiGene to Rename as BeOne Medicines
Nov. 14
 MT
BeiGene Swings to Loss in Q3; Hong Kong Shares Slide 3%
Nov. 12
 MT
BeiGene Swings to Q3 Net Loss, Revenue Rises
Nov. 12
 MT
Earnings Flash (BGNE) BEIGENE Reports Q3 Revenue $1B
Nov. 12
 MT
BeiGene, Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
Nov. 12
 CI
AstraZeneca's Former Head of Oncology in China Reportedly Under Investigation
Oct. 25
 MT
Sector Update: Health Care Stocks Softer Late Afternoon
Oct. 22
 MT
Indaptus Therapeutics Shares Rise After Pact to Develop Cancer Treatment
Oct. 22
 DJ
Top Midday Gainers
Oct. 22
 MT
BeiGene's Stomach, Esophageal Cancer Drug Receives Positive European Committee Opinions
Oct. 21
 MT
Nomura Raises Price Target on BeiGene to $293.78 From $266, Keeps Buy Rating
Oct. 21
 MT
BeiGene, Ltd. Receives Positive CHMP Opinions for TEVIMBRA as a First-Line Treatment for Advanced/Metastatic Gastricor Gastroesophageal Squamous Cell Carcinoma
Oct. 21
 CI
Nomura Adjusts BeiGene's Price Target to HK$174.91 From HK$158.37, Keeps at Buy
Oct. 21
 MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BGNE Stock
  4. News BeiGene, Ltd.
  5. Highlights